Ecolab Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bullish +25

ECL: Durable Growth, Valuation in Focus | ECL Research

Company update Dividend Earnings report AI-generated analysis

📈 Ecolab ($ECL) is a market leader in water, hygiene, and infection prevention with durable revenue growth driven by pricing power and strong consumables demand.

💰 The company reported trailing revenue of $17.4B with gross margins near the mid-40s percentage range, indicating resilient product mix and pricing strength.

⚠️ Recent earnings were mixed as EPS matched consensus but was flagged as a miss versus implied expectations, with negative year-over-year earnings growth.

🏦 Ecolab carries meaningful leverage with total debt of $13.94B and cash of $0.72B, resulting in an elevated debt-to-equity ratio of roughly 133%.

💵 Operating cash flow remains a strength at $3.03B, generating over $1.4B in free cash flow on a trailing basis to service debt and fund investments.

📊 The stock trades at a premium valuation with a trailing P/E of 40.58 and a forward P/E near 32, well above typical industrial multiples.

🎯 Analysts maintain a Strong Buy consensus rating with a mean price target near $328, implying single-digit upside from the current price of $300.68.

🔮 A fair value band is estimated between $310 and $340 per share based on blended analyst targets and conservative DCF assumptions.

🚀 Management emphasizes margin recovery and the deployment of digital solutions to drive higher-value services and validate the current premium multiple.

📅 The next quarterly report is expected in late January to February 2027, with focus on fiscal guidance and order book updates.

Bullish Signals
  • Ecolab is a market leader in water, hygiene, and infection prevention with durable revenue growth driven by pricing power and strong consumables demand.
  • Gross margins remain resilient in the mid-40s percentage range, reflecting a favorable product mix and strong pricing power across end markets.
  • Operating cash flow remains a significant strength at $3.03B, generating over $1.4B in free cash flow on a trailing basis to service debt and fund investments.
  • The company holds inclusion in the Dividend Aristocrats feature, demonstrating a history of consistent payout growth.
  • Analysts maintain a broadly positive stance with a consensus rating of Strong Buy and a mean price target near $328.
Risk Factors
  • Recent earnings were mixed as EPS matched consensus but was flagged as a miss versus the company's implied expectations.
  • Year-over-year earnings growth turned negative due to margin compression and cost pressures weighing on profitability despite revenue gains.
  • The stock trades at a premium valuation with a trailing P/E of 40.58, significantly above typical industrial and basic materials multiples.
  • The company carries meaningful leverage with total debt around $13.94B and cash around $0.72B, resulting in an elevated debt-to-equity ratio of roughly 133%.
  • Liquidity metrics show a current ratio near 1.11 and a quick ratio below 1 at roughly 0.77, highlighting working capital management challenges.
Full Analysis
Ecolab Inc. ($ECL) is a global market leader in water, hygiene, and infection prevention solutions serving foodservice, healthcare, hospitality, and industrial sectors. The company combines chemical formulations with digital monitoring and services to improve operational performance while reducing resource consumption. Analysts view the business as having durable revenue growth driven by pricing power and strong demand for consumables across its end markets. Financially, Ecolab reported trailing revenue of approximately $17.4 billion with low double-digit year-over-year growth. Gross margins remain resilient in the mid-40s percentage range, reflecting a favorable product mix. However, recent earnings have been mixed; while EPS matched consensus estimates, it was flagged as a miss relative to implied expectations, and year-over-year earnings growth turned negative due to margin compression and cost pressures. The stock trades at a premium valuation with a trailing P/E of 40.58 and a forward P/E near 32, significantly above typical industrial multiples. The company carries meaningful leverage with total debt around $13.94 billion against roughly $0.72 billion in cash, resulting in a debt-to-equity ratio of approximately 133%. Despite this leverage, operating cash flow remains robust at $3.03 billion, generating over $1.4 billion in free cash flow on a trailing basis. Analysts maintain a broadly positive stance with a consensus rating of Strong Buy and a mean price target near $328, implying single-digit upside from the current price of $300.68. The investment thesis hinges on management's ability to execute margin recovery and convert digital initiatives into meaningful earnings growth to justify the elevated multiple. A fair value band is estimated between $310 and $340 per share based on blended analyst targets and DCF models.